IMPLANET announced that its JAZZ Cap® technology has been patented in Japan. Primarily developed to facilitate the treatment of adult degenerative disorders, JAZZ Cap® is an exclusive, unique and comprehensive solution for protecting the fixation of screws in poor quality bone, a factor in 10 to 30% of vertebral fusion cases. This technology, which has already received CE mark in Europe and FDA clearance in the United States, represents an alternative to cement augmented pedicle screws and addresses a potential market estimated at $2.5 billion. The JAZZ Cap® solution has been used in the United States in surgeries in complex adult deformity indications and has provided encouraging post-operative clinical results. This latest protection further expands Implanet’s patent portfolio, which includes 31 patents specifically devoted to the JAZZ(TM) platform.